Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.
about
Drug nanocrystals: A way toward scale-upInjected nanocrystals for targeted drug deliveryNanosizing of drugs: Effect on dissolution rateNanotechnology-based cosmeceuticalsAdvances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public HealthAn Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions.Optimization of the sonication process for meloxicam nanocrystals preparation.Clarithromycin dissolution enhancement by preparation of aqueous nanosuspensions using sonoprecipitation technique.Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability.Preparation, characterization, and in vitro/vivo studies of oleanolic acid-loaded lactoferrin nanoparticles.Preclinical studies of N₃-O-toluyl-fluorouracil-loaded lipid-based nanosuspensions in H₂₂-bearing mice.Effects of oridonin nanosuspension on cell proliferation and apoptosis of human prostatic carcinoma PC-3 cell line.High drug-loading nanomedicines: progress, current status, and prospects.Studies on pharmacokinetics and tissue distribution of bifendate nanosuspensions for intravenous delivery.Analytical methods for dissolution testing of nanosized drugs.Influence of formulation and processing variables on properties of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution.Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation.A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system.New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosisPreparation and evaluation of inhalable itraconazole chitosan based polymeric micellesPreparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken designElucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112.Nanosuspension: An approach to enhance solubility of drugsNitrendipine nanocrystals: its preparation, characterization, and in vitro-in vivo evaluation.Formulation of nimodipine nanocrystals for oral administration.Comparison of protein- and polysaccharide-based nanoparticles for cancer therapy: synthesis, characterization, drug release, and interaction with a breast cancer cell line.Testing the nanoparticle-allostatic cross-adaptation-sensitization model for homeopathic remedy effectsSilver sulfadiazine nanosystems for burn therapyBile salt/phospholipid mixed micelle precursor pellets prepared by fluid-bed coating.Formulation and particle size reduction improve bioavailability of poorly water-soluble compounds with antimalarial activity.Past and future evolution in colloidal drug delivery systems.Turning Waste into Value: Nanosized Natural Plant Materials of Solanum incanum L. and Pterocarpus erinaceus Poir with Promising Antimicrobial Activities.Hybrid nanocrystals: University of Kentucky US20060280680A1.Process optimization and evaluation of novel baicalin solid nanocrystalsDrug nanoparticles: formulating poorly water-soluble compounds.Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: significantly improved antitumor efficacy.Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs.Formulation and Evaluation of Nanocrystals of a Lipid Lowering AgentHomeopathic medications as clinical alternatives for symptomatic care of acute otitis media and upper respiratory infections in children.Neuroprotective effects of a nanocrystal formulation of sPLA(2) inhibitor PX-18 in cerebral ischemia/reperfusion in gerbils
P2860
Q26744024-9711B036-9BBB-4849-902E-895911C72841Q26752396-E823FE0C-D95E-4C2A-8B8F-1EBF35644C4BQ26781058-99234F65-B1E6-4A86-B9B9-83428E640A24Q26828457-E119CC09-E857-464E-9476-6A2B183C78E7Q28384520-DA460D18-10A2-4304-B5EA-FE74367BD209Q30375813-277AEA7C-E45F-4919-973E-1D391E645221Q30397925-AC5B70BB-2A93-451B-AD3B-7C8A49302F94Q30430057-CA3537BA-9626-4077-B24F-7BC3FD0DD1A4Q30459146-B28ABA2A-2E63-44E2-94B8-3D1B8B9C9CF2Q33686640-DA96A1D8-C33A-48D3-8726-8AF9B5192FA2Q33709579-1CCFE183-DCB0-481A-933B-C2E804A79B4DQ33735835-124152A6-08D0-455A-80EB-5822FD83DBE6Q33766568-F117F892-774C-450E-A4A6-E8077492E8D8Q34102022-489209F5-C58A-4AD8-8A35-7CB00277CD8AQ34299947-9390214D-2A36-4025-85FA-6CA63C3D4262Q34323630-A0F0B086-C64C-41DA-BFFB-84A726B237AEQ34409932-D982B08D-F5F4-46E0-9FE4-3C8A8F076F9AQ34454233-2283904B-C90F-4862-800D-CEEC85018562Q34456015-442C485D-0CA3-4FAE-A970-2ABEE1AE3C2EQ34564171-F967DD97-29A2-40CF-95D6-9359042DBB24Q35024394-C25FB082-8FFB-4992-91F0-1A664D9F7484Q35284235-F2614FD2-F455-499D-935C-5B9A0ADFFA60Q35554511-D486DC18-47ED-4B2B-B995-4191641D0CBAQ35577252-2BD084C9-7FB9-4277-BB07-0029B8ED74C9Q35846349-06001C08-3C89-463C-8902-B6247A616C1EQ35992063-07E8E22A-DBB4-483C-8B7C-7E233D46053FQ36515121-D17B73B1-0AAA-443D-A43A-09AECCE11B7DQ36636579-8F236E34-4E04-46DF-B3DE-15748708D6BAQ36805049-EA3F0EF0-DDA8-441D-BD90-DF23E0C10D3BQ36882689-4404F2BF-5188-4CAE-8029-C662871CDD5CQ37039030-CDD8BB26-0891-48CF-B765-2BDC32BD4D2AQ37063880-BA6D7180-A41A-448F-BEE0-3F8D022F1928Q37093395-4B08712E-97B8-4626-AF6E-0FEDB3D26B99Q37103479-A1BA2F43-F690-43F4-AF99-39B71AAA880BQ37109079-D6EE5FF3-0C89-46F1-9A74-A4CF020CF2DAQ37118978-834C5E74-38E9-4343-AFB4-217AAC0E4725Q37141404-46DBED12-85C1-4CC7-8BA3-BFA434A8D9E1Q37178104-19E4E48A-1939-4CB6-86AA-EF23A2BC6D6BQ37324073-8581DBF9-4778-4932-AC3B-EA64D86E25DDQ37343248-F4B22F22-C381-4FBC-B8E1-FFCA9ED96048
P2860
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.
@ast
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.
@en
type
label
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.
@ast
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.
@en
prefLabel
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.
@ast
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.
@en
P1476
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
@en
P2093
Rainer H Müller
P356
10.1016/J.EJPB.2005.05.009
P407
P577
2005-08-29T00:00:00Z